References
- Cherry JD, Heiniger V. Pertussis and other Bordetella infections. Textbook of Pediatric Infectious Diseases5th edn, RD Feigin, JD Cherry, GJ Demmler, S Kaplan. W.B.Saunders, Philadelphia 2004; 1588–608
- Edwards KM, Decker MD. Pertussis vaccine. Vaccines4th edn, SA Plotkin, WA Orenstein. W.B.Saunders, Philadelphia 2004; 471–528
- Halperin SA. Pertussis: a disease and vaccine for all ages. N Engl J Med 2005; 353: 1615–7
- Wendelboe AM, van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24: S59–61
- Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32: 1691–7
- Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin Infect Dis 1999; 28: 1230–7
- Cherry JD, Beer T, Chartrand SA, deVille J, Beer E, Olsen MA, et al. Comparison of values of antibody to Bordetella pertussis in young German and American men. Clin Infect Dis 1995; 20: 1271–4
- Campins-Marti M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration. Vaccine 2002; 20: 641–6
- Edwards KM. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?. Clin Infect Dis 2001; 32: 1698–9
- Pertussis. In: Pickering L, ed. Red Book: 2003 report of the Committee on Infectious Diseases. Elk Grove Village, III. American Academy of Pediatrics, 2003: 472.
- Ward JI, Cherry JD, Chang SJ, Partige S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555–63
- Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, et al. An adult formulation of a 5-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000; 18: 1312–9
- Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, Riffelmann M, et al. Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population. Vaccine 2006; 24: 2043–8
- Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons aged 1–65 y. J Infect Dis 1996; 173: 1256–9
- van der Wielen M, van Damme P, van Herck K, Schlegel-Haueter S, Siegrist CA. Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine 2003; 21: 2412–7
- Cherry JD. Epidemiological, clinical and laboratory aspects in adults. Clin Infect Dis 1999; 28: S112–7
- Hewlett EL, Halperin SA. Serological correlates of immunity to Bordetella pertussis. Vaccine 1998; 20: 1899–900
- Leef M, Elkins KL, Barbic J, Shahin RD. Protective immunity to Bordetella pertussis requires both B cells and CD4 cells for key functions other than specific antibody production. J Exper Med 2000; 191: 1841–52
- Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serological correlates of immunity to Bordetella pertussis cough. Vaccine 1998; 16: 1901–6
- Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16: 1907–16
- He Q, Viljanen MK, Ölander RM, Bogaerts H, de Grave D, Ruuskanen O, et al. Antibodies to filamentous haemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J Infect Dis 1994; 170: 705–8
- Lionis C, Chatziarsenis M, Antonakis N, Gianoulis Y, Fioretos M. Assessment of vaccine coverage of schoolchildren in 3 primary health care areas in rural Crete, Greece. Fam Pract 1988; 15: 443–8
- Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, et al. Seroepidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece. J Clin Laborat Anal 2004; 18: 211–4
- Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39: 20–8
- Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate?. Pediatrics 2005; 115: 1675–84